Global Medical Device
Registration Services
Move a medical device, IVD, or SaMD portfolio into multiple markets through one coordinated registration program. Pure Global aligns regulatory pathways, builds a reusable core dossier, manages local submissions, and keeps approvals current after launch.
One Program,
Multiple Approvals
Our Market Access page explains the full commercial and regulatory journey. This service is narrower and execution-focused: we turn a defined market plan into country-specific registration packages, submissions, authority responses, approvals, renewals, and controlled changes. A central program lead coordinates local regulatory specialists so the same evidence is reused without treating different jurisdictions as interchangeable.
Global Market
Research
We assist you with identifying which markets to expand to leveraging existing registrations and approvals.
Classification
And Grouping
Our local regulatory experts provide strategic support to determine classification of your product portfolio and the number of registrations that are required.
Market access
requirements
Based on the classification of your products, we can outline the required steps and information to obtain your registration.
Plan, Compile,
and Submit
A successful multi-market program begins with the product, not a country checklist. We establish the intended use, device family, risk profile, existing approvals, quality-system status, and commercial sequence before building the submission plan. The result is one controlled registration program with explicit local adaptations for each authority.
Portfolio and pathway map
Classify each device and IVD, identify viable reliance or abridged routes, map local testing and representation requirements, and sequence markets around the evidence already available.
Reusable core dossier
Organize administrative, technical, clinical, labeling, risk, software, and quality evidence into a controlled source package, then create traceable local versions instead of rebuilding from zero.
Local submission and review support
Prepare forms and country annexes, coordinate translations, submit through local channels, manage deficiency questions, and maintain a decision log across authorities.
Keep Every
Registration Current
Approval is not the end of registration work. Product changes, new manufacturers, label revisions, distributor appointments, renewals, annual listings, and post-market signals can all affect a live authorization. We connect those events to a single portfolio record so deadlines and market-specific actions remain visible.
Renewals and recurring filings
Track expiry dates, annual establishment or device-listing obligations, local representative renewals, government fees, and evidence updates before they interrupt market access.
Change impact assessment
Evaluate design, manufacturing, labeling, legal-manufacturer, supplier, and distributor changes against each registration and coordinate the required notifications or amendments.
Post-market handoff
Connect registrations with complaint, vigilance, field-action, and regulatory-monitoring workflows so local obligations are not separated from the global quality system.
A Controlled Path from Evidence to Approval
Engage us for one market or use the same program structure to coordinate a portfolio across regions.
Regulatory Strategy
Classification, pathway, evidence-gap, grouping, reliance-route, and market-sequencing decisions before submission work begins.
Dossier Compilation
Structured collection, review, gap closure, localization, and version control for technical and administrative documentation.
Local Submissions
Authority filing, local-language coordination, deficiency responses, government-fee administration, and approval tracking.
Lifecycle Maintenance
Renewals, amendments, listings, distributor updates, regulatory monitoring, and registration-impact assessment for product changes.
Global Medical Device Registration FAQs
The scope normally begins with classification, regulatory pathway, grouping, evidence-gap analysis, and a market sequence. It can then include dossier compilation, local forms, translations, in-country representation, authority submission, deficiency responses, government-fee coordination, approval tracking, renewals, and change maintenance. The exact work depends on the device, risk class, existing approvals, target markets, and the manufacturer's quality-system readiness. Pure Global defines those boundaries in a market-by-market plan before execution begins.
Market access is the umbrella: it covers regulatory strategy, registration, representation, pricing, and post-market support. Global registration services focus on the operational path from a chosen market strategy to an active authorization. The page therefore emphasizes dossiers, submissions, authority questions, approvals, renewals, and change control rather than repeating the full market-access proposition.
A controlled core dossier can usually supply much of the same device description, design, risk, verification, clinical, software, labeling, and quality evidence across markets. It is not a universal submission. Classification, grouping, forms, certificates, local testing, language, labeling, fees, representation, and authority-specific evidence still vary. We preserve one evidence source while recording every local adaptation, which reduces duplication without assuming that one approval automatically opens another market.
There is no defensible single global timeline. A notification or reliance route may take weeks or a few months, while a high-risk review involving local testing, quality-system evidence, clinical questions, or multiple review rounds can take substantially longer. Our market pages show the regulator, pathway, typical evidence, and current planning ranges for each jurisdiction. A project schedule is confirmed only after classification and a dossier-readiness review.
No. FDA states that establishment registration and device listing do not denote approval, clearance, or authorization. A device that requires a 510(k), De Novo, PMA, or other premarket authorization must complete that route separately. See the FDA's registration and listing reminders and our United States market guidance before describing a product as FDA cleared or approved.
The authorization enters a lifecycle. The manufacturer must monitor renewal and listing dates, assess product and manufacturing changes, keep local labels and representative details current, respond to authority requests, and connect vigilance or field actions to each affected market. We can maintain that registration record and coordinate local actions, while the manufacturer retains its non-delegable legal and quality responsibilities.
One Core Dossier,
Multiple Markets
Reuse controlled evidence across jurisdictions while preserving the classifications, forms, representation, labeling, and authority interactions that remain local.
Let's Talk,
Anywhere You Are.
Whether looking for more information or ready to partner with us, we're here to guide you through every step of the regulatory process.
Contact us